Ms. Laura Zipoli Monaco is a pharmacist who is specialized in Oncology in Austin, Texas. Patients can reach her at 6204 Balcones Dr, Austin or contact her on 512-427-9448. Active license number of Ms. Laura Zipoli Monaco is 32387 for Oncology in Texas. Ms. Laura Zipoli Monaco is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Ms. Laura Zipoli Monaco speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Ms. Laura Zipoli Monaco
Specialization:
Oncology
Credentials:
RPH
Gender:
Female
Location:
6204 Balcones Dr, Austin, Texas, 78731-4214
Phone:
512-427-9448
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Ms. Laura Zipoli Monaco are as mentioned below.
NPI Number:
1639290661
NPI Enumeration Date:
03 Apr, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Ms. Laura Zipoli Monaco are as mentioned below.
Specialization
License Number
State
Status
Oncology
32387
Texas
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
11901 Mustang Chase, Austin, Texas
Zip:
78727-6629
Phone Number:
512-231-8450
Fax Number:
--
Patients can reach Ms. Laura Zipoli Monaco at 6204 Balcones Dr, Austin, Texas or can call on phone at 512-427-9448.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.